MCID: SCL025
MIFTS: 36

Scleromyxedema malady

Categories: Rare diseases, Skin diseases

Aliases & Classifications for Scleromyxedema

About this section
Sources:
45NIH Rare Diseases, 51Orphanet, 65UMLS, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Scleromyxedema:

Name: Scleromyxedema 45 51 65
Generalized Lichenoid Papular Eruption 45 51
Arndt-Gottron Disease 45 51
 
Generalized Papular and Sclerodermoid Lichen Myxedematosus 51
Generalized Papular and Sclerodermoid 45

Classifications:

Orphanet: 51 
Rare skin diseases


External Ids:

Orphanet51 167635
ICD10 via Orphanet28 L98.5
MESH via Orphanet37 D053718
UMLS via Orphanet66 C0263390
UMLS65 C0263390

Summaries for Scleromyxedema

About this section
NIH Rare Diseases:45 Scleromyxedema is a rare, severe skin disorder. signs and symptoms include abnormal accumulation of mucin in the skin (mucinosis), causing papular and sclerodermoid bumps; increased production of fibroblasts (connective tissue cells) in the absence of a thyroid disorder; and monoclonal gammopathy (abnormal proteins in the blood). it often involves internal organs and may affect various body systems. the cause of scleromyxedema is not known. management may involve the use of intravenous immunoglobulin (ivig) and/or plasmapheresis, but no standard treatment exists. last updated: 4/18/2014

MalaCards based summary: Scleromyxedema, also known as generalized lichenoid papular eruption, is related to scleromyxedema without monoclonal gammopathy and papular mucinosis. An important gene associated with Scleromyxedema is ACTC1 (Actin, Alpha, Cardiac Muscle 1), and among its related pathways are Cardiac Progenitor Differentiation and VEGF Signaling. Affiliated tissues include skin, thyroid and brain, and related mouse phenotypes are cardiovascular system and homeostasis/metabolism.

Wikipedia:68 Papular mucinosis (also known as \"Scleromyxedema,\" \"Generalized lichen myxedematosus,\" and... more...

Related Diseases for Scleromyxedema

About this section

Graphical network of the top 20 diseases related to Scleromyxedema:



Diseases related to scleromyxedema

Symptoms for Scleromyxedema

About this section

Drugs & Therapeutics for Scleromyxedema

About this section

Interventional clinical trials:

Search ClinicalTrials, NIH Clinical Center for Scleromyxedema

Genetic Tests for Scleromyxedema

About this section

Anatomical Context for Scleromyxedema

About this section

MalaCards organs/tissues related to Scleromyxedema:

33
Skin, Thyroid, Brain, Liver, Prostate, Endothelial, Colon

Animal Models for Scleromyxedema or affiliated genes

About this section

MGI Mouse Phenotypes related to Scleromyxedema:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.0ACTC1, F13A1, FGF2, PIK3C2A
2MP:00053767.7ACTC1, F13A1, FGF2, PIK3C2A

Publications for Scleromyxedema

About this section

Articles related to Scleromyxedema:

(show top 50)    (show all 167)
idTitleAuthorsYear
1
Successful treatment of scleromyxedema with melphalan and dexamethasone followed by thalidomide maintenance therapy. (27118492)
2016
2
Scleromyxedema without paraproteinemia. (26971585)
2016
3
Scleromyxedema Clinically Resembling to Scleroderma. (26951784)
2016
4
Scleromyxedema. (26858056)
2016
5
Scleromyxedema (papular mucinosis) with dermato-neuro syndrome: A rare, potentially fatal complication. (26051450)
2015
6
Scleromyxedema, a therapeutic dilemma. (25814746)
2015
7
Scleromyxedema. (25366027)
2014
8
Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy. (23681113)
2013
9
Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema. (23866873)
2013
10
Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis? (21671910)
2012
11
Scleromyxedema: a cutaneous paraneoplastic syndrome associated with thymic carcinoma. (22162593)
2012
12
Scleromyxedema vs scleredema: a diagnostic challenge. (21771713)
2011
13
Cardiomyopathy in scleromyxedema: report of a fatal case. (20977988)
2010
14
Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare. (19638067)
2010
15
Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. (19249127)
2009
16
Scleromyxedema with myopathy was successfully treated by thalidomide. (18435730)
2009
17
Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema. (18583794)
2008
18
Unusual granulomatous variant of scleromyxedema. (18485525)
2008
19
Scleroderma-like acute renal crisis in a patient with scleromyxedema. (17389621)
2007
20
Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study. (16822907)
2006
21
Can scleromyxedema be differentiated from nephrogenic fibrosing dermatopathy by the distribution of the infiltrate? (17083697)
2006
22
Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. (15987294)
2005
23
Successful treatment of scleromyxedema with dexamethasone cyclophosphamide pulse therapy. (16394362)
2005
24
Thalidomide as a potential treatment for scleromyxedema. (15023770)
2004
25
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. (15243538)
2004
26
Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a. (14760958)
2004
27
A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema. (15280830)
2004
28
Successful treatment of intractable scleromyxedema with cyclosporin A. (14657639)
2003
29
Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activity. (12498227)
2002
30
Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis. (12100695)
2002
31
The neurologic complications of scleromyxedema. (11552085)
2001
32
Scleromyxedema: possible association with seminoma. (10767692)
2000
33
Scleromyxedema. (10426928)
1999
34
Fever, convulsions and coma in scleromyxedema: a "dermato-neuro syndrome". (8649597)
1996
35
Scleromyxedema. (7601944)
1995
36
Extracorporeal photochemotherapy: a potentially useful treatment for scleromyxedema. (1791229)
1991
37
Scleromyxedema: case for therapeutic suggestion. (2340934)
1990
38
Stimulation of fibroblasts by paraprotein in scleromyxedema. (2808811)
1989
39
Scleromyxedema associated with non-Hodgkin lymphoma. (2592130)
1989
40
Scleromyxedema: therapeutic response to isotretinoin in three patients. (3170809)
1988
41
Plasmapheresis in a patient with scleromyxedema. (3107482)
1987
42
Scleromyxedema with systemic involvement mimics rheumatic diseases. (2943292)
1986
43
Treatment of scleromyxedema with etretinate. (6715602)
1984
44
Major surgery and scleromyxedema. (6230537)
1984
45
Scleromyxedema associated with IgG lambda multiple myeloma. (6416712)
1983
46
Scleromyxedema - a sclerodermoid disorder. (7288775)
1981
47
Scleromyxedema --report of a case with hyperpolygammopathy and immunoglobulin and complement deposition in cutaneous lesions--. (6997351)
1980
48
Scleromyxedema myopathy. Histochemical and electron microscopic observations. (645644)
1978
49
Scleromyxedema. (813582)
1976
50
Scleromyxedema. (5761799)
1969

Variations for Scleromyxedema

About this section

Expression for genes affiliated with Scleromyxedema

About this section
Search GEO for disease gene expression data for Scleromyxedema.

Pathways for genes affiliated with Scleromyxedema

About this section

Pathways related to Scleromyxedema according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.1ACTC1, FGF2
2
Show member pathways
9.1FGF2, PIK3C2A
39.1FGF2, PIK3C2A

GO Terms for genes affiliated with Scleromyxedema

About this section

Cellular components related to Scleromyxedema according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1blood microparticleGO:00725629.3ACTC1, F13A1

Biological processes related to Scleromyxedema according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1phosphatidylinositol-mediated signalingGO:00480159.1FGF2, PIK3C2A
2phosphatidylinositol-3-phosphate biosynthetic processGO:00360929.1FGF2, PIK3C2A
3phosphatidylinositol biosynthetic processGO:00066618.8FGF2, PIK3C2A

Sources for Scleromyxedema

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet